DrugPatentWatch Database Preview
SANCUSO Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Sancuso patents expire, and what generic alternatives are available?
Sancuso is a drug marketed by Kyowa Kirin and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has forty patent family members in thirty-one countries.
The generic ingredient in SANCUSO is granisetron. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the granisetron profile page.
US ANDA Litigation and Generic Entry Outlook for Sancuso
There have been two patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.
Indicators of Generic Entry
Summary for SANCUSO
| International Patents: | 40 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 36 |
| Clinical Trials: | 15 |
| Patent Applications: | 5,675 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SANCUSO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SANCUSO |
| DailyMed Link: | SANCUSO at DailyMed |
Recent Clinical Trials for SANCUSO
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Radboud University | Phase 4 |
| Milton S. Hershey Medical Center | Phase 2 |
| Temple University | Phase 3 |
Pharmacology for SANCUSO
| Drug Class | Serotonin-3 Receptor Antagonist |
| Mechanism of Action | Serotonin 3 Receptor Antagonists |
Paragraph IV (Patent) Challenges for SANCUSO
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| SANCUSO | FILM, EXTENDED RELEASE;TRANSDERMAL | granisetron | 022198 | 2015-10-09 |
US Patents and Regulatory Information for SANCUSO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kyowa Kirin | SANCUSO | granisetron | FILM, EXTENDED RELEASE;TRANSDERMAL | 022198-001 | Sep 12, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SANCUSO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0407280 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2004069141 | Start Trial |
| China | 102526043 | Start Trial |
| Russian Federation | 2005127599 | Start Trial |
| Georgia, Republic of | P20084390 | Start Trial |
| Germany | 602004007888 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
